Bluejay Therapeutics expands management team and hired Christopher Holterhoff as senior Vice President, head of business development
He will be a member of Bluejay’s Executive team, reporting to Keting Chu, Founder and CEO of Bluejay Therapeutics.
- He will be a member of Bluejay’s Executive team, reporting to Keting Chu, Founder and CEO of Bluejay Therapeutics.
- “I am delighted to welcome Chris to the senior leadership team at Bluejay”, stated Mrs. Chu.
- “Chris has an outstanding track record in business & corporate development with both public and private biotech and pharma companies.
- Before joining Bluejay, he served as VP, Business & Corporate development at LEXEO Therapeutics, where he led all business development, strategic transactions and played a significant role in the company’s capital raising activities.